Bevenopran

N/A

Report date: 2023/04/23 15:17:08
NME

Base Information

Drug NameBevenopran
Drug Alias Name贝文诺仑bevenopranum贝维普兰倍福普兰CB-5945 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor antagonists
TargetsMu opioid receptor
Therapy Area/IndicationsOpioid-Induced ConstipationConstipationRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCubist Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsOpioid-Induced ConstipationConstipationRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG